Compound B as an angiogenic agent in combination with human...

Details Compound B as an angiogenic agent in combination with human... Compound B as an angiogenic agent in combination with human...

2007-05-29

2007-05-29

Weber, Jon (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S399000, C530S350000

Reexamination Certificate

active

11008175

ABSTRACT:
Compound B is shown to promote angiogenesis, specifically, budding of capillaries. The combination of Compound B and with human growth factor, such as bFGF, shows synergistic angiogenetic effects.

REFERENCES:
patent: 5998364 (1999-12-01), Borelli et al.
patent: 6855684 (2005-02-01), Ziche et al.
patent: 94 14959 (1994-07-01), None
patent: 97 39765 (1997-10-01), None
Folkman, “Clinical Application of Research on Angiogenesis”,Seminars in Medicine of the Beth Israel Hospital, Boston, 333(26):1757-1763, Dec. 29, 1995.

Affiliated with

Also associated with

Rating

Compound B as an angiogenic agent in combination with human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compound B as an angiogenic agent in combination with human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound B as an angiogenic agent in combination with human... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3786397